miR-155 regulates physiological angiogenesis but an miR-155-rich microenvironment disrupts the process by promoting

Yuechao Dong1, Florian Alonso1, Tiya Jahjah1

  • 1Univ. Bordeaux, INSERM, Centre de Recherche cardio-thoracique de Bordeaux, U1045, 33000, Bordeaux, France.

Insights

A controlled level of microRNA-155 (miR-155) is crucial for blood vessel formation (angiogenesis). Dysregulation of miR-155 impacts neovascularization, highlighting its role in both normal and abnormal blood vessel growth.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Background:

  • Angiogenesis is regulated by vascular endothelial growth factor and Notch signaling.
  • The role of microRNAs in angiogenesis is not well understood.
  • MicroRNAs are small non-coding RNAs that regulate gene expression.

Purpose of the Study:

  • To investigate the role of microRNA-155 (miR-155) in angiogenesis.
  • To determine how miR-155 affects neovascularization and related cellular processes.
  • To elucidate the molecular mechanisms by which miR-155 regulates angiogenesis.

Main Methods:

  • Mouse retina angiogenesis model.
  • In vitro cell assays.
  • miR-155 mimics and antimiR-155 treatments.
  • Analysis of Notch signaling pathway components and Smad1/5 expression.

Main Results:

  • AntimiR-155 altered neovascularization in vivo.
  • Endogenous miR-155 is involved in podosome formation, proteolysis, and cell migration, but not morphogenesis.
  • miR-155 overexpression promoted hypersprouting and phenocopied Notch deficiency.
  • miR-155 overexpression reduced Notch signaling by decreasing Smad1/5 expression, impairing tip cell invasive capacity and morphogenesis.

Conclusions:

  • miR-155 is a novel regulator of physiological angiogenesis.
  • miR-155 plays a role in pathological angiogenesis.
  • Modulating miR-155 levels could offer therapeutic strategies for angiogenesis-related disorders.